Rare
lephants
Screener
Toggle theme
Kiniksa Pharmaceuticals International, plc
KNSA
·
Healthcare, Drug Manufacturers - General
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
Sales Per Share
Compare
←
5Y
10Y
MAX
→
Sales Per Share
Chart
Table
Fiscal Year
Sales Per Share
FY2022
$3.13
FY2023
$3.76
FY2024
$5.93
FY2025
$8.58
Download CSV
